18.09.2017
- An older version of a thyroid drug made by Merck Serono is planned to be reintroduced in France after more than 9,000 of the country's three million users complained of serious...
14.10.2015
- As part of its "Fit for 2018" strategic transformation and growth program, Germany’s Merck KGaA has rebranded itself both in design and corporate structure. With the rebranding...
15.09.2015
- Merck Serono, the biopharmaceutical arm of Germany’s Merck KGaA, has laid the cornerstone for a new €65 million laboratory at its Darmstadt headquarters. When completed in 2017...
11.03.2015
- Merck Serono, the biopharmaceutical business of Germany's Merck KGaA, and US biotechnology company Illumina, based at San Diego, California, plan to collaborate on expanding the...
24.09.2014
- Switzerland's Merck Serono, the biopharmaceuticals arm of Germany's Merck KGaA, and US biopharmaceuticals producer Sutro Biopharma have agreed a collaboration and license agreement...
17.09.2014
- Merck Serono, the biopharmaceutical division of Merck KGaA has decided to discontinue the clinical development program of its investigational MUC1 antigen-specific cancer...
25.07.2014
- Merck Serono, the biopharmaceuticals arm of Germany's Merck KgaA, is extending by two years its 10-year R&D cooperation with San Raffaele University & Research Hospital for...
17.07.2014
- Merck Serono, the biopharmaceutical division of Germany's Merck KGaA has appointed Luciano Rossetti as executive vice president and global head of research & development with...
